Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia

International Journal of Infectious Diseases

Volumn 70, Issue , 2018, Pages 51-56

  Ahmed, Anwar E ^a   Al Jahdali, Hamdan ^a   Alshukairi, Abeer N ^b   Alaqeel, Mody ^a   Siddiq, Salma S ^c   Alsaab, Hanan ^c   Sakr, Ezzeldin A ^c   Alyahya, Hamed A ^c   Alandonisi, Munzir M ^c   Subedar, Alaa T ^c   Aloudah, Nouf M ^d   Baharoon, Salim ^a   Alsalamah, Majid A ^a   Al Johani, Sameera ^a   Alghamdi, Mohammed G ^c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Early diagnosis; MERS CoV case definitions; Pneumonia; Saudi Arabia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE LEVEL; ALGORITHM; ARTICLE; ASPARTATE AMINOTRANSFERASE LEVEL; CAMEL; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PNEUMONIA; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY; ANIMAL; CLINICAL TRIAL; COMPLICATION; CORONAVIRUS INFECTION; EARLY DIAGNOSIS; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PROGRAM DEVELOPMENT; RISK; VALIDATION STUDY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANIMALS; CAMELUS; CASE-CONTROL STUDIES; CORONAVIRUS INFECTIONS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGRAM DEVELOPMENT; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK; SAUDI ARABIA; YOUNG ADULT;

EID: 85044570409     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2018.03.005     Document Type: Article

References (39)

1. Ahmed, A.E., McClish, D.K., Schubert, C.M., Accuracy and cost comparison in medical testing using sequential testing strategies. Stat Med, 2011, 3416–3430.
2. Ahmed, A.E., Schubert, C.M., McClish, D.K., Reducing cost in sequential testing: a limit of indifference approach. Stat Med, 2013, 2715–2727.
3. Ahmed, A.E., McClish, D.K., Schubert, C.M., Believe the extreme (BE) strategy at the optimal point: what strategy will it become?. Austin Biom Biostat, 2(3), 2015, 1022.
4. Ahmed, A.E., Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia. Int J Infect Dis 1:62 (2017), 47–51.
5. Ahmed, A.E., Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: a worldwide study. Epidemiol Infect, 2017, 1–7.
6. Ahmed, A.E., The predictors of 3- and 30-day mortality in 660 MERS-CoV patients. BMC Infect Dis, 17(1), 2017, 615.
7. Al Johani, S., Hajeer, A.H., MERS-CoV diagnosis: an update. J Infect Public Health, 2016, 216–219.
8. Al-Dorzi, H.M., Aldawood, A.S., Khan, R., Baharoon, S., Alchin, J.D., Matroud, A.A., et al. The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study. Ann Intens Care, 2016, 101.
9. Al-Tawfiq, J.A., Hinedi, K., Ghandour, J., Khairalla, H., Musleh, S., Ujayli, A., et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis, 2014, 160–165.
10. Aleanizy, F.S., Mohmed, N., Alqahtani, F.Y., Mohamed, R.A., Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study. BMC Infect Dis, 2017, 23.
11. Alraddadi, B.M., Watson, J.T., Almarashi, A., Abedi, G.R., Turkistani, A., Sadran, M., et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis, 2016, 49.
12. Anon, Laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV). 2018 http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1.
13. Anon, Case definition and surveillance guidance - updated June 2015. 2018 www.moh.gov.sa/en/CCC/Regulations/Case%20Definition.pdf.
14. Arabi, Y.M., Al-Omari, A., Mandourah, Y., Al-Hameed, F., Sindi, A.A., Alraddadi, B., et al. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med 45:10 (2017), 1683–1695.
15. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis, 2013, 752–761.
16. Azhar, E.I., Hashem, A.M., El-Kafrawy, S.A., Sohrab, S.S., Aburizaiza, A.S., Farraj, S.A., et al. Detection of the Middle East respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. MBio, 5(4), 2014 e01450-14.
17. Azhar, E.I., El-Kafrawy, S.A., Farraj, S.A., Farraj, S.A., Hassan, A.M., Al-Saeed, M.S., Hashem, A.M., et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370:26 (2014), 2499–2505.
18. Badawi, A., Ryoo, S.G., Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis, 2016, 129–133.
19. Choi, W.S., Kang, C.I., Kim, Y., Choi, J.P., Joh, J.S., Shin, H.S., et al. Clinical presentation and outcomes of Middle East Respiratory Syndrome in the Republic of Korea. Infect Chemother 48:June (2) (2016), 118–126.
20. Corman, V., Müller, M., Costabel, U., Timm, J., Binger, T., Meyer, B., et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Eurosurveillance, 17(49), 2012, 20334.
21. Corman, V., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance, 17(39), 2012.
22. Etzioni, R., Kooperberg, C., Pepe, M., Smith, R., Gann, P.H., Combining biomarkers to detect disease with application to prostate cancer. Biostatistics, 2003, 523–538.
23. Kim, K.H., Tandi, T.E., Choi, J.W., Moon, J.M., Kim, M.S., Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect, 2017, 207–213.
24. Mohd, H.A., Memish, Z.A., Alfaraj, S.H., McClish, D., Altuwaijri, T., Alanazi, M.S., et al. Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia. Travel Med Infect Dis 14:5 (2016), 464–470.
25. Al Muhairi, S., Al Hosani, F., Eltahir, Y.M., Al Mulla, M., Yusof, M.F., Serhan, W.S., et al. Epidemiological investigation of Middle East respiratory syndrome coronavirus in dromedary camel farms linked with human infection in Abu Dhabi Emirate, United Arab Emirates. Virus Genes 52:6 (2016), 848–854.
26. Oboho, I.K., Tomczyk, S.M., Al-Asmari, A.M., Banjar, A.A., Al-Mugti, H., Aloraini, M.S., et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med 372:9 (2015), 846–854.
27. Pepe, M.S., Thompson, M.L., Combining diagnostic test results to increase accuracy. Biostatistics, 2000, 123–140.
28. Reeves, T., Samy, A.M., Peterson, A.T., MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map. BMC Res Notes, 2015, 801.
29. Saad, M., Omrani, A.S., Baig, K., Bahloul, A., Elzein, F., Matin, M.A., et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29:December (2014), 301–306.
30. Sabir, J.S., Lam, T.T., Ahmed, M.M., Li, L., Shen, Y., Abo-Aba, S.E., et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351:6268 (2016), 81–84.
31. Shen, C., On the principles of believe the positive and believe the negative for diagnosis using two continuous tests. J Data Sci, 2008, 189–205.
32. Sherbini, N., Iskandrani, A., Kharaba, A., Khalid, G., Abduljawad, M., Hamdan, A.J., Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data. J Epidemiol Glob Health, 2017, 29–36.
33. Sidransky, D., Emerging molecular markers of cancer. Nat Rev Cancer, 2002, 210.
34. Su, J.Q., Liu, J.S., Linear combinations of multiple diagnostic markers. J Am Stat Assoc, 1993, 1350–1355.
35. Sung, H., Yong, D., Ki, C.S., Kim, J.S., Seong, M.W., Lee, H., et al. Comparative evaluation of three homogenization methods for isolating Middle East respiratory syndrome coronavirus nucleic acids from sputum samples for real-time reverse transcription PCR. Ann Laborat Med, 2016, 457–462.
36. Thompson, M.L., Assessing the diagnostic accuracy of a sequence of tests. Biostatistics, 2003, 341–351.
37. Youden, W.J., Index for rating diagnostic tests. Cancer, 1950, 32–35.
38. Younan, M., Bornstein, S., Gluecks, I.V., MERS and the dromedary camel trade between Africa and the Middle East. Trop Anim Health Prod, 2016, 1277–1282.
39. Zaki, A.M., Van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:19 (2012), 1814–1820.